Literature DB >> 25959136

Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection.

Ana Avellon1, Lucia Morago1, Maria Garcia-Galera del Carmen1, Milagros Munoz1, Jose-Manuel Echevarría1.   

Abstract

Hepatitis E virus (HEV) acute infection is often diagnosed only by anti-HEV IgM ELISA methods, whose sensitivity varies, according to different reports. Reports assessing the specificity of commercial assays for anti-HEV IgG testing are scarce, and estimates of sensitivity and specificity are both controversial. The aim of this work is to assess the sensitivity of different commercial techniques for HEV genotype 3 antibody (anti-HEV) IgM and IgG detection in entirely specific sample panels including both high and low antibody concentrations. The anti-HEV IgM and IgG ELISA methods compared were: DSI, Mikrogen, Wantai, Euroimmun, MP, and Dia.pro. The rapid test All Diag was also included in the anti-HEV IgM comparison. Our results show that low anti-HEV IgM concentrations were better detected by DSI, Mikrogen, and All Diag, these tests being the most sensitive in our study. Euroimmun, MP and Dia.pro gave concordant results, showing lower sensitivity than the others. Regarding anti-HEV IgG our results revealed similar anti-HEV IgG sensitivity. Furthermore, there was a striking overall lack of concordance among the results. We present a thorough review of previous comparative reports, with particular reference to the anti-HEV IgG comparison, since published results differ from ours. This discrepancy may be related to the improved versions of the tests for MP and Dia.pro that we employed.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  HEV; IgG; IgM; anti-HEV; comparative sensitivity

Mesh:

Substances:

Year:  2015        PMID: 25959136     DOI: 10.1002/jmv.24251

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  27 in total

Review 1.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

2.  Seroprevalence of hepatitis E virus among blood donors in northern Italy (Sondrio, Lombardy) determined by three different assays.

Authors:  Cristina Galli; Laura Fomiatti; Catia Tagliacarne; Claudio Velati; Alessandro R Zanetti; Silvana Castaldi; Luisa Romanò
Journal:  Blood Transfus       Date:  2017-10       Impact factor: 3.443

3.  Development of an oral fluid immunoassay to assess past and recent hepatitis E virus (HEV) infection.

Authors:  Nora Pisanic; Atiqur Rahman; Samir K Saha; Alain B Labrique; Kenrad E Nelson; Douglas A Granger; Steve W Granger; Barbara Detrick; Christopher D Heaney
Journal:  J Immunol Methods       Date:  2017-05-03       Impact factor: 2.303

4.  Performance of Hepatitis E Virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany.

Authors:  Frauke Mara Sommerkorn; Birgit Schauer; Thomas Schreiner; Helmut Fickenscher; Andi Krumbholz
Journal:  Med Microbiol Immunol       Date:  2017-04-10       Impact factor: 3.402

5.  Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort Study.

Authors:  Heléne Norder; Marie Karlsson; Åsa Mellgren; Jan Konar; Elisabeth Sandberg; Anders Lasson; Maria Castedal; Lars Magnius; Martin Lagging
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

6.  Seroprevalence of Hepatitis A Virus, Hepatitis E Virus, and Helicobacter pylori in Rural Communities of the Bolivian Chaco, 2013.

Authors:  Irene Campolmi; Michele Spinicci; David Rojo Mayaregua; Herlan Gamboa Barahona; Antonia Mantella; Yunni Lara; Mimmo Roselli; Marianne Strohmeyer; Giampaolo Corti; Francesco Tolari; Joaquín Monasterio Pinckert; Harry R Dalton; Alessandro Bartoloni
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

7.  High prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disorders in eastern Poland.

Authors:  Anna Parfieniuk-Kowerda; Jerzy Jaroszewicz; Tadeusz W Łapiński; Mariusz Łucejko; Magdalena Maciaszek; Magdalena Świderska; Anna Grzeszczuk; Beata Naumnik; Mirosław Rowiński; Robert Flisiak
Journal:  Arch Med Sci       Date:  2018-12-05       Impact factor: 3.318

8.  A Novel Blocking ELISA for Detection of Antibodies against Hepatitis E Virus in Domestic Pigs.

Authors:  Yiyang Chen; Qin Zhao; Baoyuan Liu; Lizhen Wang; Yani Sun; Huixia Li; Xinjie Wang; Shahid Faraz Syed; Gaiping Zhang; En-Min Zhou
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

9.  A Public Health initiative on hepatitis E virus epidemiology, safety and control in Portugal--study protocol.

Authors:  João R Mesquita; Mette Myrmel; Kathrine Stene-Johansen; Joakim Øverbø; Maria S J Nascimento
Journal:  BMC Infect Dis       Date:  2016-01-16       Impact factor: 3.090

10.  Prevalence and clinical correlation of hepatitis E virus antibody in the patients' serum samples from a tertiary care hospital in Thailand during 2015-2018.

Authors:  Atiporn Boonyai; Anchalee Thongput; Thidarat Sisaeng; Parisut Phumchan; Navin Horthongkham; Wannee Kantakamalakul; Chutikarn Chaimayo
Journal:  Virol J       Date:  2021-07-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.